Ann Arbor, MI10 Active Studies

Essential Tremor Clinical Trials in Ann Arbor, MI

Find 10 actively recruiting essential tremor clinical trials in Ann Arbor, MI. Connect with local research sites and explore new treatment options.

10
Active Trials
9
Sponsors
2,089
Enrolling

Recruiting Essential Tremor Studies in Ann Arbor

RecruitingAnn Arbor, MINCT04474223

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)

Fetal complete (i.e., third degree, 3°) atrioventricular block (AVB), identified in the 2nd trimester of pregnancy in an otherwise normally developing heart, is almost universally associated with mate...

1,300 participants
NYU Langone Health
View Study Details
RecruitingAnn Arbor, MINCT06351631

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bome...

400 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingAnn Arbor, MINCT06627179

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

The purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa (RP) due to mutations in...

81 participants
Laboratoires Thea
View Study Details
RecruitingAnn Arbor, MINCT05594563

TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answer are: * Does it reduce stress on the cells that make insu...

70 participants
Emily K. Sims
View Study Details
RecruitingAnn Arbor, MINCT02934568

Ribociclib (LEE011) Rollover Study for Continued Access

This study is to allow continued use of ribociclib (LEE011) as single agent or in combination with other investigational treatments in patients benefitting from treatment in an eligible Novartis-spons...

50 participants
Novartis Pharmaceuticals
View Study Details
RecruitingAnn Arbor, MINCT06401356

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

The purpose of this study is to evaluate the long-term safety and the clinical benefit of pelabresib in patients with hematological and/or solid tumor indications or advanced malignancies. Additionall...

50 participants
Novartis Pharmaceuticals
View Study Details
RecruitingAnn Arbor, MINCT06646289

A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)

The purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adults and children with X-linked retinitis ...

42 participants
Janssen Research & Development, LLC
View Study Details
RecruitingAnn Arbor, MINCT05507892

Renal Mechanism of SGLT2 Inhibition

Canagliflozin is an oral drug which is currently approved for use in patients with type 2 diabetes by the US Food and Drug Administration (FDA). Canagliflozin acts by increasing salt and sugar loss in...

40 participants
University of Colorado, Denver
View Study Details
RecruitingAnn Arbor, MINCT06777433

Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases

This is an open-label, single dose, single arm, multicenter Phase 2b study to establish the imaging performance of RAD101 PET in participants who are ≥ 18 years of age and with suspected recurrent bra...

30 participants
Radiopharm Theranostics, Ltd
View Study Details
RecruitingAnn Arbor, MINCT05504291

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

This phase II trial tests the safety and side effects of adding melphalan (by injecting it into the eye) to standard chemotherapy in early treatment of patients with retinoblastoma (RB). RB is a type ...

26 participants
Children's Oncology Group
View Study Details

About Essential Tremor Clinical Trials in Ann Arbor

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 10 essential tremor clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 2,089 participants. Research is being sponsored by NYU Langone Health, Merck Sharp & Dohme LLC, Laboratoires Thea and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Ann Arbor — FAQ

Are there essential tremor clinical trials in Ann Arbor?

Yes, there are 10 essential tremor clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 10 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated March 2, 2026 from ClinicalTrials.gov